Search results
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 4 days agoElsewhere, GSK is streamlining its operations. Last week it sold off its remaining stake in consumer...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 6 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
AstraZeneca to pay $107.5M for cancer drug patent infringement
Becker’s Hospital Review· 6 days agoAstraZeneca has been ordered to pay $107.5 million to Pfizer in damages for infringing Pfizer's patents, Reuter's reported May 17. A jury found that Tagrisso ...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 1 day agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In...
Benzinga via Yahoo Finance· 1 day agoA Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused...
Octapharma USA Appoints New VP of Commercial Marketing & Development
New Jersey Business Magazine· 6 days agoOctapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as vice president of...
Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?
Medscape· 5 days agoIn February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 4 days agoNonetheless, “management's successful track record” in delivering on its promises could give credibility to the company’s goal, Welford added. “[T]he new...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 4 days ago“We don’t yet know if the manufacturers will have patient assistance programs.” Vaccine...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoIs Novavax's stock a buy? This string of good news follows Novavax's announcement about three months...
